DRUGRECURE ApS

CVR 29154406 · Private limited company (ApS) · Active · Medium risk

DRUGRECURE ApS is a Private limited company (ApS), founded on , based in København K. The company is registered in the industry traditionelle, komplementære og alternative behandlingsformer. Our model estimates a bankruptcy risk of 2.6% over the next 12 months, which is 1.9 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -1.4bn and a net result of DKK -282.4m. CEO: Danielle Marie Brown.

Bankruptcy risk for DRUGRECURE ApS

2.6%
probability of bankruptcy within 12 months
Medium risk

1.9 × the average (1.41%) · higher risk than 86% of active Danish companies

Lowest riskHighest risk

Increases the risk

Moves in the last 2 years2 · bankruptcy rate 23.9%2.7×
Equity ratio< -50% · bankruptcy rate 19.3%2.2×
CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×

Reduces the risk

Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
CEOs in total (historical)5+ · bankruptcy rate 3.8%0.43×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
29154406
Status
Active
Company type
Private limited company (ApS)
Founded
(21 years)
Address
c/o Mazanti-Andersen Advokatpartnerselskab, Amaliegade 10
1256 København K
Municipality
København
Industry
Traditionelle, komplementære og alternative behandlingsformer (869600)
Bankruptcies in the industry: Praktiserende tandlæger
Share capital
DKK 162k
Auditor
Grant Thornton, Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 20
Missing annual reportNo
Negative equityYes
Equity ratio-1,484.9%
Current ratio6%
Moves (last 2 years)2
CEO changes in total10
CEO's previous bankruptcies0
Other companies at the address94
Going-concern uncertaintyYes

Financials and key figures

Financial year20252024
Gross profitDKK -231.1mDKK -227.5m
Net profitDKK -282.4mDKK -274.6m
EquityDKK -1.4bnDKK -1.1bn
Total assetsDKK 91.6mDKK 27.5m
Short-term debtDKK 1.5bn–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Grant Thornton, Godkendt Revisionspartnerskab - København.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025180
1 Jan 2024 – 31 Dec 2024174
1 Jan 2023 – 31 Dec 2023179
1 Jan 2022 – 31 Dec 202262
1 Jan 2021 – 31 Dec 2021178
1 Jan 2020 – 31 Dec 2020154
1 Jan 2019 – 31 Dec 2019155
1 Jan 2018 – 31 Dec 2018151
1 Jan 2017 – 31 Dec 2017164
1 Jan 2016 – 31 Dec 2016165
1 Jan 2015 – 31 Dec 2015158
1 Jan 2014 – 31 Dec 2014162
1 Jan 2013 – 31 Dec 2013105
1 Jan 2012 – 31 Dec 2012159
1 Jan 2011 – 31 Dec 2011177
1 Jan 2010 – 31 Dec 2010180
1 Jan 2009 – 31 Dec 2009159
1 Jan 2008 – 31 Dec 2008158
1 Jan 2007 – 31 Dec 2007154
1 Nov 2005 – 31 Dec 2006165

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEODanielle Marie BrownCurrent
CEOPeter Andreas Stakemann
CEOTom Glæsner Larsen
CEOLars Heslet
CEOSøren Bech Justesen
CEORobert Norman Neville
CEODavid Lee Lowrance
BoardLars Heslet
BoardLeif Helth Jensen
BoardEric Jean Marie Leire
BoardKaare Fiala
BoardPeter Høngård Andersen
Owner (100%)Savara ApSCurrent
Owner (100%)Serenova A/S
AuditorGrant Thornton, Godkendt RevisionspartnerselskabCurrent
AuditorERNST & YOUNG DENMARK P/S
AuditorGRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorPRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderApS KBUS 38 nr.3117Current

The CEOs' other companies

Peter Andreas Stakemann – 54 other companies, of which 54 bankrupt

Tom Glæsner Larsen – 53 other companies, of which 15 bankrupt

Lars Heslet – 11 other companies, of which 3 bankrupt

Søren Bech Justesen – 10 other companies

Address history (11 moves)

c/o Mazanti-Andersen Advokatpartnerselskab, Amaliegade 10, 1256 København K
c/o C/O Mazanti-Andersen Advokatpartnerselsk, Amaliegade 10, 1256 København K
c/o Lundgrens Advokatpartnerselskab (LP), Tuborg Boulevard 12, 4., 2900 Hellerup
Slotsmarken 17, 1. th, 2970 Hørsholm
Slotsmarken 17, 2. tv, 2970 Hørsholm
Slotsmarken 12, 1. th, 2970 Hørsholm
c/o Cobis, Ole Maaløes Vej 3, 2200 København N
Bøge Alle 5, 1. tv, 2970 Hørsholm
Agern Alle 3, 2970 Hørsholm
Kongevejen 153, 2830 Virum
Grusbakken 8, 2820 Gentofte
Kronprinsessegade 18, 1306 København K

Former names

DRUGRECURE ApS – now
ApS KBUS 17 NR. 4495 –

Other companies at the same address

Similar companies in København

Questions and answers about DRUGRECURE ApS

Has DRUGRECURE ApS gone bankrupt?

No, DRUGRECURE ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of DRUGRECURE ApS?

Our model estimates a bankruptcy risk of 2.6% over the next 12 months (medium risk), which is 1.9 times the average for Danish companies.

Who is the CEO of DRUGRECURE ApS?

Danielle Marie Brown is the CEO of DRUGRECURE ApS.

Who is the auditor of DRUGRECURE ApS?

DRUGRECURE ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.

When was DRUGRECURE ApS founded?

DRUGRECURE ApS was founded on 1 November 2005.

What is the equity of DRUGRECURE ApS?

Equity was DKK -1.4bn according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.